Introduction
Anhui Shafeng Advanced Material Co., Ltd. (安徽沙丰新材料有限公司) is a Chinese specialty materials manufacturer focused on fatty acid derivatives, especially metal stearates and related additives used in plastics, rubber, petrochemicals, cosmetics, and pharmaceutical applications. The company was founded in 2014 in Quanjiao County, Anhui Province, and later became a controlled subsidiary of Anhui Jiaxian Functional Auxiliary Co., Ltd. after a 2020 acquisition of a 67% equity stake. Its product portfolio includes calcium stearate, zinc stearate, magnesium stearate, sodium stearate, zinc laurate, water-dispersion products, and other ester-based materials, reflecting its position in the specialty additives segment of the plastics supply chain.
Shafeng’s manufacturing model combines research and development, production, and sales, and company materials describe the use of automated production lines and DCS control systems to support batch consistency and reproducibility. The company reports an annual capacity of 70,000 tonnes and emphasizes product characteristics such as low free acid content, low moisture content, and stable thermal performance, which are important in PVC processing, lubricant systems, and stabilization formulations. In industry directories and trade-platform listings, the company is identified as a supplier to plastics and rubber markets, underscoring its role as a midstream additive producer serving compounders, processors, and formulation specialists.
History and Development
Anhui Shafeng was established in 2014 with an initial investment of RMB 80 million and developed as an integrated enterprise combining research, production, and sales of fatty acid derivatives. Company and third-party materials indicate that an initial production phase began in 2016, with early output centered on multi-grade calcium stearate and its emulsion products, along with zinc stearate, magnesium stearate, monoglycerides, and PETS.
A significant development occurred in 2020, when Anhui Jiaxian Functional Auxiliary Co., Ltd. acquired 67% of Shafeng New Materials for RMB 90.45 million, a transaction described in the listed acquirer’s disclosure as part of its effort to expand product variety and build new growth drivers. After the acquisition, the company became a state-controlled subsidiary under the Jiaxian group structure.
The company was also listed in Chinese government programs for technology-oriented small and medium-sized enterprises in 2018, 2020, and 2021, indicating continued recognition within the national innovation-support framework.
Business Operations and Segments
Shafeng operates as a specialty chemical and additives producer with an integrated model covering formulation development, manufacturing, and sales. Its business is organized around fatty acid salts and derivatives, which are used in several industrial and consumer-facing sectors.
Its reported business focus includes:
- Metal stearates and related salts
- Fatty acid esters
- Fatty acid amides
- Water-dispersion products
- Pharmaceutical excipients and other application-specific formulations
The company’s location in Shitan Modern Industrial Park, Quanjiao County, places it within an industrial logistics corridor connected to major rail and expressway networks, a factor relevant to bulk chemical distribution and regional customer service.
Products and Technologies
Shafeng’s core product range centers on metal soaps and related derivatives used as processing aids, lubricants, stabilizers, and release agents. The company’s stated product lineup includes calcium stearate, zinc stearate, magnesium stearate, sodium stearate, zinc laurate, hydrated calcium stearate solutions, hydrated zinc stearate solutions, hydroxystearates, and behenates.
Its product and process profile suggests several technical priorities:
- Low free acid content, which matters for compatibility in plastics and rubber formulations.
- Low moisture content, which is important for storage stability and process consistency.
- Batch-to-batch stability, a key quality requirement for additive masterbatches and PVC formulations.
- Automated production and DCS control, used to improve reproducibility and uniformity.
The company also states that it operates a pharmaceutical excipient line aligned with GMP principles and references compliance with standards such as USP, EP, CP, JP, and GB for relevant product categories. That positioning indicates that part of its portfolio serves not only industrial polymers but also regulated life-science and food-adjacent markets where specification control is more stringent.
Applications and End Markets
Shafeng’s products are used across several industrial sectors, with the strongest linkage to plastics processing and PVC formulation. Public company materials and trade listings identify applications in:
- PVC stabilizers
- Plastic modification
- Masterbatches and functional masterbatches
- Petrochemical premixes
- Rubber processing
- Pharmaceutical excipients
- Cosmetics
In plastics, metal stearates typically function as internal and external lubricants, acid scavengers, and release agents, helping to improve processing behavior, demolding, and thermal stability in polymer compounding and profile extrusion. Shafeng’s stated emphasis on thermal stability and consistent batch quality aligns with these typical industry requirements.
Global Presence and Market Position
The company is headquartered in Anhui Province, China, and is described in supplier directories and exhibition platforms as a plastics and rubber supplier with activity in domestic and international trade channels. Company materials state that its products are used by customers in petrochemicals, rubber, plastics, and cosmetics, and its distribution footprint appears to be centered on Chinese industrial markets with export-oriented visibility through business directories and trade listings.
Within the broader market for metal stearates and fatty acid derivatives, Shafeng occupies the role of a specialty additive producer rather than a commodity polymer maker. That position places it in a competitive segment shaped by formulation quality, consistency, regulatory compliance, and application support, rather than by scale in base resin production.
Research and Development
R&D is a stated part of the company’s operating model, with Shafeng describing itself as a combined R&D, production, and sales enterprise. It also refers to an in-house R&D base and the use of advanced production equipment and process technology, indicating that product development is tied closely to process control and application performance.
The company’s inclusion in multiple Chinese technology enterprise and technology-oriented SME lists suggests formal recognition of its innovation activity and technical capacity. In a sector such as metal stearates, R&D typically focuses on particle characteristics, dispersion behavior, thermal performance, and adaptation to customer-specific formulations, all of which are consistent with the product claims made in company materials.
Sustainability and Environmental Initiatives
Shafeng positions some of its products and processes around stability, consistency, and efficient processing, which can support lower scrap rates and more reliable downstream manufacturing in plastics and rubber applications. Its product range also includes formulations intended for regulated applications, where controlled composition and traceability are important operational requirements.
As with many specialty chemical producers serving plastics markets, the company’s environmental profile is shaped by the industrial use of metal soaps and fatty acid derivatives, which are valued in part for process efficiency and formulation performance. Public materials reviewed here emphasize product quality and manufacturing control more strongly than they detail emissions, energy, or circular-economy initiatives.
Financial Performance and Economic Impact
The company was founded with an investment of RMB 80 million, and the 2020 equity transaction valued the acquired 67% stake at RMB 90.45 million. Those figures indicate a mid-sized specialty materials business with sufficient commercial scale to attract strategic acquisition by a listed industrial parent.
Shafeng contributes economically through the supply of specialty additives used in plastics compounding, rubber processing, and allied industries, supporting domestic manufacturing chains that depend on formulation additives rather than primary polymers alone. Its reported 70,000-tonne annual capacity suggests a meaningful manufacturing footprint within China’s additives sector.
Quality Management and Certifications
Shafeng states that its pharmaceutical excipient production line follows GMP requirements and that product quality conforms to standards including USP, EP, CP, JP, and GB for applicable products. These references indicate a quality-management approach oriented toward both domestic and international specification frameworks.
The company also emphasizes uniformity, reproducibility, and batch stability in production, which are particularly important in additives markets where small variations can affect PVC stabilization, lubrication performance, and downstream processability.
Innovations and Future Outlook
Shafeng’s development trajectory suggests continued emphasis on specialty fatty acid derivatives, tighter process control, and application-specific formulations. Its integration into a larger industrial group may support broader market access, procurement stability, and product development resources.
Future competitiveness in the plastics additives segment will likely depend on the company’s ability to maintain specification consistency, adapt products to evolving PVC and masterbatch requirements, and sustain technical service across regulated and industrial end markets.
References
- •
CPS+ eMarketplace. (n.d.). ANHUI SHAFENG ADVANCED MATERIAL CO., LTDANHUI SHAFENG ADVANCED MATERIAL CO., LTD. CPS+ eMarketplace. https://www.chinaplasonline.com/eMarketplace/ExhibitorInfo?CompId=1033340Link